-
effectivehealthcare.ahrq.gov/products/renal-artery-stenosis/research
October 24, 2006 - blood pressure control, preservation of kidney function, flash pulmonary edema, other cardiovascular events … What adverse events and complications have been associated with aggressive medical therapy or renal artery
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - drug events (ADEs), increased healthcare utilization (e.g., emergency department visits,
acute care … drug
events, adverse drug withdrawal
events, mortality)
Implementation measures
(e.g., barriers … Adverse drug events in ambulatory care. … Clarifying adverse drug events: a clinician's guide to
terminology, documentation, and reporting. … Reducing Adverse Drug Events in Older Adults.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
May 01, 2017 - • Benefits of TT placement must
be weighed against a variety of
adverse events. … Key Question 3: What adverse events, surgical
complications, and sequelae are associated with inserting … Median percentage of patients and ears with adverse events associated with TT
placement
Adverse Event … Other adverse
events, such as hearing loss and cholesteatoma, are likely
confounded by the severity … Future trials would
benefit from standardization and consistent definition of
adverse events.
-
effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Developing Indicators of Inpatient Adverse Drug
Events Through Non-Linear Analysis Using Administrative … Real-Time Vaccine Safety Surveillance for the
Early Detection of Adverse Events. … Evaluation and Overview
of the National Electronic Injury Surveillance System- Cooperative Adverse … A Simulation-Based Evaluation of
Methods to Estimate the Impact of an Adverse Event on Hospital Length
-
effectivehealthcare.ahrq.gov/products/arthritis-knee-physical-therapy/research
November 06, 2012 - Adverse events were uncommon and not severe enough to deter participants from continuing treatment. … Adverse events were uncommon and not severe enough to deter participants from continuing treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea_research-protocol.pdf
March 15, 2010 - Intra-operative events
b. Surgical recovery events
c. Surgical recovery time
d. … Harms, Adverse events
a. Any adverse events
KQ 2, 5
7. … Cardiovascular events (Congestive heart failure symptoms, stroke, arrhythmia
events, coronary artery … Harms, Adverse events
a. Any adverse events
KQ 6-7
• Adherence / Compliance
a. … events: No minimum duration
o Post-surgery: minimum 6 weeks (except adverse events)
• Prospective
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - As in the original report, the new trial reported no serious
adverse events. … No adverse events were reported in the NSAID arm; other
harms were not reported. … No adverse events were reported. … No serious adverse events or withdrawal due to adverse events were reported.
12
The other two new … reported no postoperative complications of adverse
events from cold compression.
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
January 01, 2009 - events. … events. … drug events, no response)
Events rates markedly different than in community Event rates in treatment … events) was chosen. … events.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-fecal-incontinence-supporting.pdf
June 19, 2020 - Three of the treatment-related adverse events were assessed as serious. … No serious adverse events occurred. … Adverse
events were collected. … The
most common adverse events (AEs) were proctalgia (13.3%) and pyrexia (9.6%). … No long-term side effects or serious adverse events were reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - However, concerns over potential
adverse events associated with antiobesity pharmacotherapies have … cardiovascular events.
2
Amid concerns over various adverse events, three drugs in late-phase development … Another expert with a research perspective expressed concern about adverse gastrointestinal events … The potential was tempered by experts’ significant concerns about adverse events
reported thus far. … However, multiple experts also noted the significant side effects and adverse events reported and the
-
effectivehealthcare.ahrq.gov/products/migraine-prevention/research-2013
April 18, 2013 - with random-effects models and with Bayesian network meta-analysis, and calculated numbers of outcome events … effects, and 26 (95% CI, 10 to 43) would discontinue treatments due to bothersome adverse effects. … Adverse effects leading to treatment discontinuation were examined in 68 RCTs. … effects and treatment discontinuation due to adverse effects. … discontinuation due to adverse effects.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/OCD-key-questions.pdf
January 01, 2022 - OCD Diagnosis
(KQ1)
Intervention delivery: different care
settings and care intensities (KQ4)
Adverse … effects of
diagnosis:
Safety outcomes,
adverse events,
misdiagnosis,
unnecessary diagnostics … Adverse effects of treatment:
Safety outcomes, adverse
events
Potential Effect Modifiers
• Severity … Comparator Usual care
Outcomes Accuracy of diagnosis, risk of misdiagnosis, and possible
adverse … function
and competence/need for special accommodations,
quality of life, acceptability of treatment, adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
February 01, 2014 - , revascularization procedures, serious
adverse events, LDL-c, and HDL-c. … Outcomes and
Timing
Included clinical outcomes—mortality, cardiovascular events, cerebrovascular events … Included adherence and harms outcomes—adherence, serious adverse events (as reported by investigators … ),
withdrawal due to adverse events, cancer, elevated liver transaminases, adverse +musculoskeletal … events, regardless of statin potency.
-
effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research-protocol
October 14, 2014 - events during therapy for the “intent to treat analysis” in order to determine which patients would … events
Patient adherence
Long-term clinical outcomes
All-cause mortality
Quality of life … after transplant
Major adverse cardiac events
Malignancy
Infections
timing of infections
clinical … The adverse events and harms reported by any study included to address any of the questions will be used … to assess harms and adverse events related to therapeutic monitoring of CNIs and CNI treatment strategies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
March 09, 2010 - KQ 3: In children with JIA, does the rate and type of adverse events differ
between the various DMARDs … • Adverse events: These are specific to the interventions being examined (see Table
2). … In addition, adverse events may occur at
any point after the treatment is received. … • Case control studies are acceptable to assess for adverse events of DMARD treatment
(KQ3, KQ4) … Event Reporting System (AERS) from July 2008 to June 2009 for
adverse events related to JIA treatment
-
effectivehealthcare.ahrq.gov/products/gestational-diabetes-screening-diagnosis/research-protocol
December 16, 2011 - events. … We will report adverse events as they are reported by the authors of the study. … Examples of adverse events that we have identified a priori are listed in KQ5 above. … with an adverse event. … Hyperglycemia and adverse pregnancy outcome (HAPO) study Cooperative Research Group.
-
effectivehealthcare.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
May 27, 2016 - can lead to
adverse events. … Peer reviewer #5 Background The list of adverse events is organized poorly. … “Safety events (also known as adverse events include):…”
This is a good place to acknowledge the public … The focus should be on adverse events. … How this relates to harm and adverse
events is not articulated well.
-
effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research-protocol
March 09, 2010 - KQ 3
In children with JIA, does the rate and type of adverse events differ between the various DMARDs … Adverse events: These are specific to the interventions being examined (see Table 2). … In addition, adverse events may occur at any point after the treatment is received.
Methods
A. … Case control studies are acceptable to assess for adverse events of DMARD treatment (KQ3, KQ4). … Reporting System (AERS) from July 2008 to June 2009 for adverse events related to JIA treatment with
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer/abstract
April 14, 2010 - Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy
-
effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
December 21, 2010 - Question 3
. . . clinical or intermediate harms outcomes (e.g., organ toxicity, serious adverse events … , withdrawal due to adverse events)? … Food and Drug Administration's (FDA) definition of serious adverse events will be used.24 d The languages … events
Serious adverse events (composite outcome) c
Neurologic adverse events (e.g., neuropathy, … events (composite outcome—FDA definition of serious adverse events 24 ), withdrawal due to adverse events